Cumulus Advances Alzheimer’s Research with NeuLogiq Platform
BELFAST, Northern Ireland, June 30, 2026 Cumulus Neuroscience has announced the publication of new findings in Frontiers in Digital...
FDA 510k
Advertisement
Intelligent Bio Solutions Expands Clinical Validation of Fingerprint Drug Screening Technology
NEW YORK, June 16, 2026 Intelligent Bio Solutions (INBS) announced the initiation of a critical clinical Interference Study designed...
Moderna and Oxford Launch Phase 1/2 Trial of mRNA Cancer Vaccine for Lynch Syndrome
OXFORD, UK AND CAMBRIDGE, Massachusetts – June 8, 2026 Moderna and the University of Oxford have received authorization from...
Johnson & Johnson Acquires Firefly Bio to Boost Oncology
NEW BRUNSWICK, New Jersey, USA – June 8, 2026 Johnson & Johnson has announced a definitive agreement to acquire...
Senzime Expands Pediatric Anesthesia Presence with New U.S. Hospital Contract
UPPSALA, Sweden, June 3, 2026 Senzime AB announced continued momentum in the pediatric anesthesia market with the award of...
Advertisements
Olympus Gains FDA Clearance for POWERSEAL Open Device
WESTBOROUGH, MASSACHUSETTS, April 28, 2026 Olympus Corporation has received FDA 510(k) clearance for its latest innovation, the POWERSEAL™ Open...
Philips Verida AI Spectral CT Wins FDA 510(k) Clearance
AMSTERDAM, Netherlands, April 16, 2026 Royal Philips has announced a major advancement in medical imaging with the U.S. FDA...
Intelligent Bio Advances FDA 510(k) with Cybersecurity
NEW YORK, April 17, 2026 Intelligent Bio Solutions Inc. (INBS) has strengthened its upcoming FDA 510(k) submission by successfully...
Xodus Medical Gains FDA Clearance for Hot Pink Pad
PITTSBURGH, Pa., April 17, 2026 Xodus Medical, Inc. announced the launch of its Hot Pink Pad®, following FDA 510(k)...
Intelligent Bio Advances FDA 510(k) Drug Test Program
NEW YORK, April 2, 2026 Intelligent Bio Solutions Inc. has achieved a critical milestone in its regulatory journey by...
Advertisement
